Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance

Laura Bonapace(University Children's Hospital Zurich), Jean‐Pierre Bourquin(University Children's Hospital Zurich), Martin Schrappe(University Hospital Schleswig-Holstein), Gunnar Cario, Maike Schmitz(University of Zurich), Beat Bornhäuser(University Children's Hospital Zurich), Beat W. Schäfer(University Children's Hospital Zurich), Urs Ziegler(University of Zurich), Felix Niggli(University of Zurich), Martin Stanulla(Leibniz University Hannover)
Journal of Clinical Investigation
March 8, 2010
10.1172/jci39987
Cited by 311

Related Papers

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95
|Blood|2008|607
Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region
|The Lancet|2002|400
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
|Blood|2009|347
Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008
|Leukemia|2009|338